Singulair (generic montelukast) does indeed cross the blood brain barrier; however, it is NOT linked to dementia. In fact is it being studied in clinical trials as a possible TREATMENT for Alzheimer's Disease.
Answered 6/22/2021
0 views
2 doctors weighed in across 2 answers
2 doctors weighed in across 2 answers
3 doctors weighed in across 2 answers
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question